Profil bibliographique

Robert Wurm

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

23Publications signalées

397Citations signalées

1Affiliations récentes

Institutions déclarées

Medical University of Graz

Domaines associés

Lung Cancer Treatments and MutationsLung Cancer Research StudiesCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentCancer Genomics and Diagnostics

Publications récentes

Accès ouvert 2026 articleOpenAlex

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort.

Oliver Illini, Anna-Carina Hund, Hans‐Georg Kopp, Mor Moskovitz et autres

0 citationsOpen Access CRIS of the University of Bern

Accès ouvert 2026 articleOpenAlex

Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort

Oliver Illini, Anna-Carina Hund, Hans‐Georg Kopp, Mor Moskovitz et autres

5 citationsJournal of Thoracic Oncology

Accès ouvert 2025 articleOpenAlex

Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical Practice Guidelines

Florian Moik, Gudrun Absenger, Robert Wurm, Maximilian J. Hochmair et autres

7 citationsCancers

Accès ouvert 2024 articleOpenAlex

Prognostic impact of targetable driver alterations in resected early-stage lung cancer

Angelika Terbuch, Selma Konjić, Verena Schlintl, Gudrun Absenger et autres

5 citationsTranslational Lung Cancer Research

Accès ouvert 2024 articleOpenAlex

Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study

Maximilian J. Hochmair, Angelika Terbuch, David Lang, Christian Trockenbacher et autres

1 citationCancers

Accès ouvert 2024 articleOpenAlex

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis

Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, M. Duruisseaux et autres

12 citationsInternational Journal of Molecular Sciences

Accès ouvert 2024 articleOpenAlex

Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC

Nikolaus John, Verena Schlintl, Teresa Sassmann, Joerg Lindenmann et autres

18 citationsJournal for ImmunoTherapy of Cancer

Accès ouvert 2024 articleOpenAlex

88P Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC

V. Schlintl, Nevin John, Teresa Sassmann, Joerg Lindenmann et autres

0 citationsESMO Open

Accès ouvert 2024 articleOpenAlex

Expanding Broad Molecular Reflex Testing in Non-Small Cell Lung Cancer to Squamous Histology

Martin Zacharias, Selma Konjić, Nikolaus Kratochwill, Gudrun Absenger et autres

8 citationsCancers

Accès ouvert 2023 articleOpenAlex

Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study

Dominik A. Barth, Florian Moik, Sarah Steinlechner, Florian Posch et autres

20 citationsJournal for ImmunoTherapy of Cancer

Accès ouvert 2022 articleOpenAlex

Nintedanib plus Docetaxel after Immune Checkpoint Inhibitor Failure in Patients with Advanced Non-Small-Cell Lung Cancer: A Case Series

Maximilian J. Hochmair, Rainer Kolb, Robert Wurm, Herwig Zach et autres

2 citationsCase Reports in Oncology

Accès ouvert 2022 articleOpenAlex

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

Oliver Illini, Hannah Fabikan, Aurélie Swalduz, Anders Vikström et autres

30 citationsTherapeutic Advances in Medical Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.